Pages that link to "Q35130680"

The following pages link to HER-2/neu and topoisomerase IIalpha in breast cancer (Q35130680):

Displaying 30 items.

• Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas (Q25257601) (← links)
• Topoisomerase IIalpha gene (TOP2A) amplification and deletion in cancer--more common than anticipated (Q28186346) (← links)
• Topoisomerase II alpha expression in testicular germ cell tumors (Q33283828) (← links)
• Effect of structural modification at the 4, 3', and 2' positions of doxorubicin on topoisomerase II poisoning, apoptosis, and cytotoxicity in human melanoma cells (Q33287099) (← links)
• A human recombinant autoantibody-based immunotoxin specific for the fetal acetylcholine receptor inhibits rhabdomyosarcoma growth in vitro and in a murine transplantation model. (Q33692521) (← links)
• Investigation of CD28 gene polymorphisms in patients with sporadic breast cancer in a Chinese Han population in Northeast China (Q34469269) (← links)
• A fourteen gene GBM prognostic signature identifies association of immune response pathway and mesenchymal subtype with high risk group. (Q34706701) (← links)
• Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy (Q34743488) (← links)
• The role of HER-2 in Breast Cancer (Q35068343) (← links)
• GPHMM: an integrated hidden Markov model for identification of copy number alteration and loss of heterozygosity in complex tumor samples using whole genome SNP arrays (Q35087993) (← links)
• MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers (Q35123674) (← links)
• Novel patterns of genome rearrangement and their association with survival in breast cancer (Q35173695) (← links)
• Topoisomerase IIalpha in Wilms' tumour: gene alterations and immunoexpression. (Q35770478) (← links)
• Multiplication of Chromosome 17 Centromere Is Associated with Prognosis in Patients with Invasive Breast Cancers Exhibiting Normal HER2 and TOP2A Status. (Q35866923) (← links)
• Phenotypic and genetic characterization of circulating tumor cells by combining immunomagnetic selection and FICTION techniques. (Q36725183) (← links)
• Topoisomerase II alpha gene copy loss has adverse prognostic significance in ERBB2-amplified breast cancer: a retrospective study of paraffin-embedded tumor specimens and medical charts (Q36897329) (← links)
• Therapy Insight: anthracyclines and trastuzumab--the optimal management of cardiotoxic side effects (Q37118500) (← links)
• Facts and controversies in the use of trastuzumab in the adjuvant setting (Q37263863) (← links)
• Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response (Q37406389) (← links)
• Plant derived anti-cancerous secondary metabolites as multipronged inhibitor of COX, Topo, and aromatase: molecular modeling and dynamics simulation analyses. (Q38377125) (← links)
• DNA topoisomerase-directed anticancerous alkaloids: ADMET-based screening, molecular docking, and dynamics simulation (Q38392591) (← links)
• Higher topoisomerase 2 alpha gene transcript levels predict better prognosis in GBM patients receiving temozolomide chemotherapy: identification of temozolomide as a TOP2A inhibitor (Q39439785) (← links)
• TOP2A amplification and overexpression in hepatocellular carcinoma tissues. (Q42180761) (← links)
• Doxorubicin and cyclophosphamide followed by weekly docetaxel as neoadjuvant treatment of early breast cancer: analysis of biological markers in a GEICAM phase II study (Q46156165) (← links)
• Influence of activation state of ErbB-2 (HER-2) on response to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for stage II, node-positive breast cancer: study 8541 from the Cancer and Leukemia Group B. (Q46662710) (← links)
• Recurrent Glioblastomas Exhibit Higher Expression of Biomarkers with Stem-like Properties (Q49883157) (← links)
• Topoisomerase IIalpha expression rather than gene amplification predicts responsiveness of adjuvant anthracycline-based chemotherapy in women with primary breast cancer (Q50570346) (← links)
• Prognostic value of TOP2A gene amplification and chromosome 17 polysomy in early breast cancer. (Q54318735) (← links)
• Isolated tumor cells in the bone marrow (ITC-BM) of breast cancer patients before and after anthracyclin based therapy: influenced by the HER2- and Topoisomerase IIalpha-status of the primary tumor? (Q81735795) (← links)
• Tumour topoisomerase II alpha protein expression and outcome after adjuvant dose-dense anthracycline-based chemotherapy (Q84382547) (← links)